Ypozane is a highly effective drug designed for the treatment of benign prostatic hyperplasia in male dogs.
The active component of Ypozane is osaterone acetate—a powerful androgen that acts as a progestational steroid. Osaterone acetate competitively inhibits the binding of androgens to prostate receptors and blocks the absorption of testosterone in prostate cells, leading to a reduction in prostate size by up to 40%, without affecting sperm quality.
Ypozane is recommended as an effective means of maintaining the health of male dogs suffering from benign prostatic hyperplasia and can significantly improve the quality of life of the animal without the need for radical treatment methods.
APPLICATION PROCEDURE AND DOSAGE
Administer 0.25-0.5 mg of osaterone acetate per kg, once daily for 7 days.
